2016 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2017 | 0 | 6.155.125 | 1.212.500 | 1 | ||
2016 | 0 | 8.291.218 | 745.669 | 1 |
Total number of partners: 21
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 21
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2017-12-01 | A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma. | CLINGLIO | participant | 6.155.125 | 12 |
2016-05-01 | Scaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy | PRECIOUS | participant | 8.291.218 | 11 |